Clene Nanomedicineincis A Clinical Stage Biopharmaceutical Company Based In Salt Lake Cityutahfounded In 2012Clene Focuses On Developing Innovative Nanotherapeutics Aimed At Treating Neurodegenerative Diseasesthe Company Specializes In Nanotechnology To Enhance Cellular Energy Metabolism And Reduce Oxidative Stresswith A Mission To Restore Neuronal Health And Function Clene S Key Technology Is The Clean Surface Nanocrystalcsna Cplatformwhich Produces Active Nanocrystals Designed To Improve Mitochondrial Function And Neuronal Survivaltheir Pipeline Includes Cnm Au8A Gold Nanocrystal Suspension Currently In Clinical Trials For Conditions Like Amyotrophic Lateral Sclerosisalsand Multiple Sclerosisms Clene Also Has Preclinical Programs Targeting Other Neurodegenerative Disorders The Leadership Team At Clene Brings Extensive Experience In Pharmaceutical Commercializationwith A Focus On Advancing Therapeutic Development Through Collaborations With Academic And Clinical Institutionsthe Company Aims To Become A Leader In Neurotherapeutics By Addressing Unmet Medical Needs In This Field
